[Role of test therapy with broad-spectrum antibiotics in the diagnosis of nonbacterial tuberculosis].
Test therapy with broad-spectrum antibiotics in the diagnosis of abacillary tuberculosis is indicated in the acute onset of the disease, in focal and infiltrative lung tissue changes, marked pulmonary symptoms (cough, auscultative lung changes, fever). Test therapy can be performed at any stage of diagnosis: in the outpatient setting, in a somatic or tuberculosis hospital. During test therapy, it is irrational to frequently change antibiotics or to use drugs having antituberculous activity (such as fluoroquinolones, rifampicin, most aminoglycosides). Positive X-ray changes after a course of test therapy with non-specific antibiotics is a diagnostic criterion which suggests that the disease of non-tuberculosis etiology.
Gubkina
M F
MF
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D011859:Radiography; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents